| Gene symbol | FLT3 | Synonyms | CD135, FLK-2, FLK2, STK1 | Type of gene | protein-coding |
| Chromosome | 13 | Map location | 13q12.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | fms related receptor tyrosine kinase 3 | ||||
| GTO ID | GTC2084 |
| Trial ID | NCT03904069 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | FLT3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | AMG 553 |
| Phase | Phase1 |
| Recruitment status | Withdrawn |
| Title | Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML |
| Year | 2019 |
| Country | United States |
| Company sponsor | Amgen |
| Other ID(s) | 20180091 |
| Cohort 1 | |||||||
|
|||||||